Albemarle (ALB) financial statements
Albemarle reported revenue of $5.1B in fiscal 2025, up 7.5% a year over 9 years.
Net income was -$511M and the operating margin -7.1%, against 22.4% in 2016.
Free cash flow was $692M, and the company returned $191M in dividends.
The diluted share count rose 4% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Albemarle's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.1B | $3.4B | $3.6B | $3.1B | $3.3B | $7.3B | $9.6B | $5.4B | $5.1B |
| Cost of revenue | $1.7B | $2.0B | $2.2B | $2.3B | $2.1B | $2.3B | $4.2B | $8.4B | $5.3B | $4.5B |
| Gross profit | $970M | $1.1B | $1.2B | $1.3B | $995M | $998M | $3.1B | $1.2B | $63M | $669M |
| Research and development | $80M | $84M | $70M | $58M | $59M | $54M | $72M | $86M | $87M | $51M |
| Selling, general and admin | $354M | $450M | $446M | $533M | $430M | $441M | $524M | $910M | $618M | $550M |
| Operating income | $601M | $572M | $912M | $666M | $506M | $798M | $2.5B | $252M | -$1.8B | -$367M |
| Interest expense | $65M | $115M | $52M | $58M | $73M | $61M | $123M | $116M | $166M | $208M |
| Pre-tax income | $515M | $447M | $795M | $563M | $374M | $134M | $2.4B | $247M | -$1.8B | -$552M |
| Income tax | $96M | $432M | $145M | $88M | $54M | $29M | $391M | $430M | $87M | $157M |
| Net income | $644M | $55M | $694M | $533M | $376M | $124M | $2.7B | $1.6B | -$1.2B | -$511M |
| EPS (diluted) | $5.68 | $0.49 | $6.34 | $5.02 | $3.52 | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 |
| Diluted shares | 113M | 112M | 109M | 106M | 107M | 117M | 118M | 118M | 118M | 118M |
| Gross margin | 36.2% | 36.0% | 36.1% | 35.0% | 31.8% | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% |
| Operating margin | 22.4% | 18.6% | 27.0% | 18.6% | 16.2% | 24.0% | 33.7% | 2.6% | -33.0% | -7.1% |
| Net margin | 24.0% | 1.8% | 20.6% | 14.9% | 12.0% | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
Balance sheet
Fiscal years, from Albemarle's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $2.3B | $1.1B | $555M | $613M | $747M | $439M | $1.5B | $890M | $1.2B | $1.6B |
| Receivables | $486M | $534M | $606M | $613M | $531M | $557M | $1.2B | $1.2B | $742M | $594M |
| Inventory | $450M | $593M | $701M | $769M | $750M | $799M | $2.1B | $2.2B | $1.5B | $1.2B |
| Total current assets | $3.3B | $2.5B | $2.0B | $2.2B | $2.2B | $2.0B | $5.2B | $5.2B | $3.8B | $4.0B |
| Property, plant and equipment | $2.4B | $2.5B | $3.0B | $4.9B | $5.4B | $5.9B | $7.0B | $9.5B | $9.3B | $8.6B |
| Goodwill | $1.5B | $1.6B | $1.6B | $1.6B | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B | $1.5B |
| Total assets | $8.2B | $7.8B | $7.6B | $9.9B | $10.5B | $11.0B | $15.5B | $18.3B | $16.6B | $16.4B |
| Total current liabilities | $1.1B | $1.2B | $1.2B | $1.4B | $1.8B | $1.9B | $2.7B | $3.6B | $2.0B | $1.8B |
| Long-term debt | $2.1B | $1.4B | $1.4B | $2.9B | $2.8B | $2.0B | $3.2B | $3.5B | $3.1B | $3.1B |
| Total liabilities | $4.2B | $3.9B | $3.8B | $5.8B | $6.0B | $5.2B | $7.3B | $8.6B | $6.4B | $6.6B |
| Shareholders' equity | $3.8B | $3.7B | $3.6B | $3.9B | $4.3B | $5.6B | $8.0B | $9.4B | $10.0B | $9.5B |
| Net debt | $100M | $700M | $1.1B | $2.4B | $2.8B | $2.0B | $1.7B | $3.3B | $2.3B | $1.6B |
Cash flow
Fiscal years, from Albemarle's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $736M | $304M | $546M | $719M | $799M | $344M | $1.9B | $1.3B | $688M | $1.3B |
| Capital spending | $197M | $318M | $700M | $852M | $850M | $954M | $1.3B | $2.2B | $1.7B | $590M |
| Free cash flow | $539M | -$14M | -$154M | -$132M | -$52M | -$609M | $651M | -$828M | -$993M | $692M |
| Stock-based compensation | $17M | $19M | $15M | $20M | $23M | $20M | $30M | $37M | $32M | $40M |
| Dividends paid | $135M | $141M | $145M | $152M | $162M | $178M | $184M | $187M | $189M | $191M |
| Share buybacks (net) | $0 | -$250M | -$500M | $0 | $0 | — | — | — | — | — |
| Net borrowing | -$1.3B | -$751M | $0 | $1.4B | $202M | -$1.2B | $1.3B | $327M | $0 | -$449M |
| Free cash flow margin | 20.1% | -0.4% | -4.6% | -3.7% | -1.6% | -18.3% | 8.9% | -8.6% | -18.5% | 13.5% |
| Dividends per share | $1.20 | $1.25 | $1.32 | $1.43 | $1.52 | $1.53 | $1.57 | $1.59 | $1.60 | $1.62 |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALB.
Open ALB in InvestinglyQuestions
What was Albemarle's revenue in 2025?
$5.1B in fiscal 2025, from its 10-K filing.
How much free cash flow does Albemarle generate?
$692M in fiscal 2025 (operating cash flow minus capital spending).
From Albemarle's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.